OAC
VYGR icon

OMERS Administration Corp’s Voyager Therapeutics VYGR Stock Holding History

OMERS Administration Corp’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-83,012
Closed -$326K – 1180
2025
Q4 		$326K Buy
83,012
+11,062
+15% +$48.9K ﹤0.01% 788
2025
Q3 		$336K Hold
71,950
– – ﹤0.01% 849
2025
Q2 		$224K Hold
71,950
– – ﹤0.01% 774
2025
Q1 		$243K Hold
71,950
– – ﹤0.01% 902
2024
Q4 		$408K Sell
71,950
-71,950
-50% -$464K ﹤0.01% 748
2024
Q3 		$842K Sell
143,900
-18,500
-11% -$135K 0.01% 551
2024
Q2 		$1.28M Buy
+162,400
New +$1.36M 0.01% 476

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

OMERS Administration Corp's VYGR Position: Q1 2026 in Review

OMERS Administration Corp sold out of Voyager Therapeutics (VYGR) in Q1 2026, closing a stake of 83,012 shares — an estimated $326K sold.

OMERS Administration Corp first reported a position in VYGR in Q2 2024 and held it in 7 quarters. The position peaked at $1.28M in Q2 2024. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • OMERS Administration Corp reported no remaining Voyager Therapeutics position as of Q1 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 83,012 Voyager Therapeutics shares in Q1 2026, an estimated $326K.
  • OMERS Administration Corp first reported a position in Voyager Therapeutics in Q2 2024 and held it in 7 quarters.
  • OMERS Administration Corp's Voyager Therapeutics position peaked at $1.28M in Q2 2024.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.